small molecule

XIPERE

TRIAMCINOLONE ACETONIDE

Loss of exclusivityApril 2040latest FDA-listed patent expiry
CompanyBAUSCH AND LOMB INC

Drug detail

Brand nameXIPERE
Active ingredientTRIAMCINOLONE ACETONIDE
Strength40MG/ML
Dosage formSUSPENSION
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 2021
Marketing statusRX

Listed patents

PatentExpiresType
12419833April 2040product
9937075May 2034product
9636332November 2033use U-3234
8636713May 2027use U-3234

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.